TD-1792 versus Vancomycin for Treatment of Complicated Skin and Skin Structure Infections

Methicillin-Resistant Staphylococcus aureus Central Line–Associated Bloodstream Infections in US Intensive Care Units, 1997-2007

(2009) Deron C. Burton   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Exploring the Positional Attachment of Glycopeptide/β-lactam Heterodimers

(2009) Daniel D Long et al.   JOURNAL OF ANTIBIOTICS

Heterogeneous Vancomycin‐Intermediate Susceptibility Phenotype in Bloodstream Methicillin‐ResistantStaphylococcus aureusIsolates from an International Cohort of Patients with Infective Endocarditis: Prevalence, Genotype, and Clinical Significance

(2009) In‐Gyu Bae et al.   JOURNAL OF INFECTIOUS DISEASES

International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008

(2008) Victor D. Rosenthal et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Skin and Soft‐Tissue Infections Caused by Community‐Acquired Methicillin‐ResistantStaphylococcus aureus

(2008) Martin E. Stryjewski et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology of Methicillin‐ResistantStaphylococcus aureus

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Differential Pharmacological Effects of Antimuscarinic Drugs on Heart Rate: A Randomized, Placebo-controlled, Double-blind, Crossover Study With Tolterodine and Darifenacin in Healthy Participants ≥50 Years

(2008) Brian Olshansky et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

(2007) A. Soriano et al.   CLINICAL INFECTIOUS DISEASES